These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25821590)

  • 1. Blockade of vascular endothelial growth factor receptor 1 prevents inflammation and vascular leakage in diabetic retinopathy.
    He J; Wang H; Liu Y; Li W; Kim D; Huang H
    J Ophthalmol; 2015; 2015():605946. PubMed ID: 25821590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
    Huang H; Shen J; Vinores SA
    PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.
    Miyamoto K; Khosrof S; Bursell SE; Rohan R; Murata T; Clermont AC; Aiello LP; Ogura Y; Adamis AP
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10836-41. PubMed ID: 10485912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
    Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
    Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy.
    Hollanders K; Hove IV; Sergeys J; Bergen TV; Lefevere E; Kindt N; Castermans K; Vandewalle E; van Pelt J; Moons L; Stalmans I
    Curr Eye Res; 2017 Feb; 42(2):260-272. PubMed ID: 27399806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor.
    Gong CY; Lu B; Hu QW; Ji LL
    Int J Ophthalmol; 2013; 6(5):573-7. PubMed ID: 24195027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor inhibits retinal microvascular dysfunction induced by 12/15-lipoxygenase-derived eicosanoids.
    Ibrahim AS; Tawfik AM; Hussein KA; Elshafey S; Markand S; Rizk N; Duh EJ; Smith SB; Al-Shabrawey M
    Biochim Biophys Acta; 2015 Mar; 1851(3):290-8. PubMed ID: 25562624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
    Deissler HL; Deissler H; Lang GK; Lang GE
    Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A central role for inflammation in the pathogenesis of diabetic retinopathy.
    Joussen AM; Poulaki V; Le ML; Koizumi K; Esser C; Janicki H; Schraermeyer U; Kociok N; Fauser S; Kirchhof B; Kern TS; Adamis AP
    FASEB J; 2004 Sep; 18(12):1450-2. PubMed ID: 15231732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of 12/15-Lipoxygenase in retinal endothelial cells, but not in monocytes/macrophages, attenuates high glucose-induced retinal leukostasis.
    Ibrahim AS; Saleh H; El-Shafey M; Hussein KA; El-Masry K; Baban B; Sheibani N; Wang MH; Tawfik A; Al-Shabrawey M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):636-645. PubMed ID: 28351645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents.
    Qiu AW; Liu QH; Wang JL
    Cell Physiol Biochem; 2017; 41(3):960-972. PubMed ID: 28222445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.